Jennison Associates’s Tetraphase Pharmaceuticals TTPH Stock Holding History
Bought
Maintained
Sold
Other funds holding TTPH
Jennison Associates's TTPH Position: Q3 2015 in Review
Jennison Associates sold out of Tetraphase Pharmaceuticals (TTPH) in Q3 2015, closing a stake of 56,141 shares — an estimated $53.3M sold.
Jennison Associates first reported a position in TTPH in Q2 2013 and held it in 9 quarters. The position peaked at $53.3M in Q2 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q3 2015.
- Jennison Associates reported no remaining Tetraphase Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
- Jennison Associates sold 56,141 Tetraphase Pharmaceuticals shares in Q3 2015, an estimated $53.3M.
- Jennison Associates first reported a position in Tetraphase Pharmaceuticals in Q2 2013 and held it in 9 quarters.
- Jennison Associates's Tetraphase Pharmaceuticals position peaked at $53.3M in Q2 2015.
- 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals as of Q3 2015.
Based on Jennison Associates's 13F filing for Q3 2015, filed 6 Nov 2015.